These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25595555)

  • 1. Are RNAi and miRNA therapeutics truly dead?
    Conde J; Artzi N
    Trends Biotechnol; 2015 Mar; 33(3):141-4. PubMed ID: 25595555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies.
    Deng Y; Wang CC; Choy KW; Du Q; Chen J; Wang Q; Li L; Chung TK; Tang T
    Gene; 2014 Apr; 538(2):217-27. PubMed ID: 24406620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structurally flexible triethanolamine-core poly(amidoamine) dendrimers as effective nanovectors to deliver RNAi-based therapeutics.
    Liu X; Liu C; Catapano CV; Peng L; Zhou J; Rocchi P
    Biotechnol Adv; 2014; 32(4):844-52. PubMed ID: 23938269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. siRNA nanomedicine: the promise of bioreducible materials.
    Kozielski KL; Tzeng SY; Green JJ
    Expert Rev Med Devices; 2013 Jan; 10(1):7-10. PubMed ID: 23278217
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular medicine for the brain: silencing of disease genes with RNA interference.
    Davidson BL; Paulson HL
    Lancet Neurol; 2004 Mar; 3(3):145-9. PubMed ID: 14980529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanodelivery systems for nucleic acid therapeutics in drug resistant tumors.
    Iyer AK; Duan Z; Amiji MM
    Mol Pharm; 2014 Aug; 11(8):2511-26. PubMed ID: 24661041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Advances in research on RNA interference-related drugs for cancer treatment].
    Ren HW; Yang BX
    Zhonghua Zhong Liu Za Zhi; 2012 Nov; 34(11):801-4. PubMed ID: 23291125
    [No Abstract]   [Full Text] [Related]  

  • 8. Commercial potential of RNAi.
    Jain KK
    Mol Biosyst; 2006 Nov; 2(11):523-6. PubMed ID: 17216033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA and brain tumors: a cause and a cure?
    Mathupala SP; Mittal S; Guthikonda M; Sloan AE
    DNA Cell Biol; 2007 May; 26(5):301-10. PubMed ID: 17504026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A boost for the emerging field of RNA nanotechnology.
    Shukla GC; Haque F; Tor Y; Wilhelmsson LM; Toulmé JJ; Isambert H; Guo P; Rossi JJ; Tenenbaum SA; Shapiro BA
    ACS Nano; 2011 May; 5(5):3405-18. PubMed ID: 21604810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [RNA interference and molecular pathology of selected diseases].
    Lochmanová J; Bartos M
    Cas Lek Cesk; 2008; 147(12):607-15. PubMed ID: 19235485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Running interference: prospects and obstacles to using small interfering RNAs as small molecule drugs.
    Dykxhoorn DM; Lieberman J
    Annu Rev Biomed Eng; 2006; 8():377-402. PubMed ID: 16834561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small RNA: can RNA interference be exploited for therapy?
    Wall NR; Shi Y
    Lancet; 2003 Oct; 362(9393):1401-3. PubMed ID: 14585643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanomedicine Meets microRNA: Current Advances in RNA-Based Nanotherapies for Atherosclerosis.
    Gadde S; Rayner KJ
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):e73-9. PubMed ID: 27559146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanomedicinal delivery approaches for therapeutic siRNA.
    Keller M
    Int J Pharm; 2009 Sep; 379(2):210-1. PubMed ID: 19716034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying targets for topical RNAi therapeutics in psoriasis: assessment of a new in vitro psoriasis model.
    Bracke S; Desmet E; Guerrero-Aspizua S; Tjabringa SG; Schalkwijk J; Van Gele M; Carretero M; Lambert J
    Arch Dermatol Res; 2013 Aug; 305(6):501-12. PubMed ID: 23775225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity in mice expressing short hairpin RNAs gives new insight into RNAi.
    Snøve O; Rossi JJ
    Genome Biol; 2006; 7(8):231. PubMed ID: 16942630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting.
    Kuang Y; An S; Guo Y; Huang S; Shao K; Liu Y; Li J; Ma H; Jiang C
    Int J Pharm; 2013 Sep; 454(1):11-20. PubMed ID: 23867728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [RNA interference: from origins to a novel tool for gene silencing].
    Ortiz-Quintero B
    Rev Invest Clin; 2009; 61(5):412-27. PubMed ID: 20184102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotheranostics: advanced nanomedicine for the integration of diagnosis and therapy.
    Muthu MS; Mei L; Feng SS
    Nanomedicine (Lond); 2014 Jul; 9(9):1277-80. PubMed ID: 25204816
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.